CA Patent

CA2758764C — Method for on-demand contraception using levonorgestrel or norgestrel

Assigned to Laboratoire HRA Pharma SAS · Expires 2017-04-11 · 9y expired

What this patent protects

The invention relates to a method for contraception, which method comprises on-demand administering levonorgestrel or norgestrel in a woman, within 24 hours before an intercourse.

USPTO Abstract

The invention relates to a method for contraception, which method comprises on-demand administering levonorgestrel or norgestrel in a woman, within 24 hours before an intercourse.

Drugs covered by this patent

ulipristal-acetate (ULIPRISTAL ACETATE)

Patent Metadata

Patent number: CA2758764C
Jurisdiction: CA
Classification: —
Expires: 2017-04-11
Drug substance claim: No
Drug product claim: No
Assignee: Laboratoire HRA Pharma SAS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.